| News
Early mover: NextDay.Vision is first tenant at Switzerland Innovation Park Basel Area in Jura
26.09.2019
One month before the official opening, the Jura site of the Switzerland Innovation Park Basel Area welcomes its first tenant: NextDay.Vision, a start-up from the Jura, opens its office at the park. The company was also one of the winners of the i4Challenge 2018.
Philippe Kapfer, CEO NextDay.Vision
Being in the Jura comes with advantages for the company: Customers and partners in Basel, Bern, Neuchâtel, Geneva and Paris are easily accessible by train. Being close to the many SMEs in the Jura further provides the possibility to easily deploy and improve new products, adapting them to the needs of the customers. To CEO Philippe Kapfer, the Jura site of the innovation park is the perfect place to innovate, to share and to grow. “We are convinced that the Switzerland Innovation Park Basel Area will help us in creating new partnerships and in finding new customers.” He appreciates the effort that the canton makes to attract and to keep innovative companies. “We are one of these innovators. There is no reason for us to go elsewhere,” Kapfer says.
CEO Philippe Kapfer is a cybersecurity specialist and author of a book on Internal Hacking. He founded his start-up to develop software solutions in computer security in 2017. NextDay.Vision also offers IT security consulting as well as conferences and trainings on security awareness. NextDay.Vision recently released its first product: OtpOne API replaces passwords in company business applications. “Our next plans are to develop some tools related to our technology to provide IT companies with more comfort and security. Further, we want to develop cybersecurity audits and raise awareness in order to protect local SMB companies from hackers.” NextDay.Vision also collaborates with a reseller in Canada to open new markets.
The CEO hopes for a thriving community at the innovation park and looks forward to finding complementary profiles of entrepreneurs and skills in order to work together and to create something new. Philippe Kapfer also enjoys the other qualities of the Jura: “The region is just beautiful.”
Share this article
Sign up to receive our newsletter in your inbox.
You might also be interested in
docdok.health involved in coronavirus research project
A research project is investigating the improvement in the condition of patients who have been hospitalized due to COVID-19. docdok.health based in Basel is contributing the smartphone app for the project.
Read More
Celonic agrees cooperation to combat coronavirus
The Basel-based biopharmaceutical company Celonic Group has agreed a partnership with Airway Therapeutics from the USA. Together, the two companies are planning to develop a drug to treat coronavirus.
Read More
Idorsia receives payment of 45 million US dollars
The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine Biosciences and shall also be entitled to claim milestone payments in future. Neurocrine has exercised a licensing option for a drug developed by Idorsia to treat epilepsy..
Read More
Humard robot disinfects using UV light
Humard has developed a robot that can disinfect spaces using UV light. For this, the system manufacturer from the canton of Jura has adapted a mobile industrial robot that is otherwise used in warehouse logistics.
Read More
Roche authorized to distribute coronavirus antibody tests
Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The tests are already being distributed around the world. In May, production capacities are to already be scaled up to the high double-digit million area.
Read More
Basel is the most popular Swiss location for headquarters
Basel is valued as a location for company headquarters. In a rating from the fDi Intelligence platform of the Financial Times, Basel achieves eighth place in Europe. No other Swiss city does better.
Read More
Healthtech sector growing rapidly in the Basel Area
The investment and innovation promotion agency Basel Area Business & Innovation, previously known as BaselArea.swiss, can look back on a successful year in 2019. In this regard, positive developments in the healthtech sector and in Switzerland Innovation Park Basel Area stand out.
Read More
Support program has roots in Basel
The online program Selfapy supports people suffering from mental health conditions during the coronavirus lockdown. BaselArea.swiss has provided startup help by way of its DayOne initiative.
Read More
University Hospital Basel treats coronavirus patients with plasma
The University Hospital Basel is the first Swiss hospital to have treated two Covid-19 patients with the plasma from a patient who has recovered from the virus, which means that they are receiving the appropriate antibodies. This method is a potential therapeutic option.
Read More
Botnar Research Center advancing research into coronavirus
The Basel-based Botnar Research Center for Child Health is providing capital in the amount of 15 million Swiss francs to its four partner institutions. In this way, the University of Basel should be in a position to advance research into dealing with the coronavirus outbreak.
Read More
